FIRST AIRED: August 25, 2016

Nice work! Enjoy the show!


You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!



>> Drug company, Mylan, on Thursday slashing the price of its life saving EpiPen in half. After coming under fire from consumers, Presidential candidates, and politicians on both sides of the aisle for a 400% cost surge over the past decade. The price of the standard 2-PAK now $300 through the use of a savings card.
The move coming one day after Hillary Clinton called the continuous price hike outrageous. The company stock dropping on the negative press. Earlier this week Republican Senator Chuck Grassley wrote Mylan a letter asking it to explain EpiPen's high cost. While Senator Amy Klobuchar, a Democrat, called for an investigation by the Federal Trade Commission.
The price cut boosting shares of Mylan early Thursday.